Zobrazeno 1 - 10
of 230
pro vyhledávání: '"Nobumichi Tanaka"'
Autor:
Hideyasu Tsumura, Nobumichi Tanaka, Tomohiko Oguchi, Takuya Owari, Yasushi Nakai, Isao Asakawa, Kazuyoshi Iijima, Haruaki Kato, Iwao Hashida, Ken-ichi Tabata, Takefumi Satoh, Hiromichi Ishiyama
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-9 (2022)
Abstract We compared clinical outcomes associated with seed brachytherapy (SEED-BT) alone and SEED-BT plus external-beam radiotherapy (EBRT) for intermediate-risk prostate cancer using propensity score-matched analysis. From 2006 to 2011, 993 patient
Externí odkaz:
https://doaj.org/article/0f03e922f93545728a406dc4f59cf354
Autor:
Yasushi Nakai, Nobumichi Tanaka, Isao Asakawa, Kazumasa Torimoto, Makito Miyake, Satoshi Anai, Tomomi Fujii, Masatoshi Hasegawa, Kiyohide Fujimoto
Publikováno v:
Journal of Contemporary Brachytherapy, Vol 11, Iss 5, Pp 409-416 (2019)
Externí odkaz:
https://doaj.org/article/0411d7aa6578451aa4bf1ee0d1be7f34
Autor:
Yasushi Nakai, Nobumichi Tanaka, Makito Miyake, Takeshi Inoue, Satoshi Anai, Kiyohide Fujimoto
Publikováno v:
BMC Research Notes, Vol 11, Iss 1, Pp 1-5 (2018)
Abstract Objective The objective of this retrospective study was to evaluate whether the effect of second-line therapy of flutamide after bicalutamide can predict the response to abiraterone. Results Thirty-four patients received abiraterone and 32 r
Externí odkaz:
https://doaj.org/article/af5214ec651040e88b20f6f7d288e1ba
Autor:
Kazumasa Torimoto, Yoshihiro Matsumoto, Daisuke Gotoh, Yosuke Morizawa, Makito Miyake, Shoji Samma, Nobumichi Tanaka, Akihide Hirayama, Kiyohide Fujimoto
Publikováno v:
BMC Research Notes, Vol 11, Iss 1, Pp 1-5 (2018)
Abstract Objectives Several studies have shown the relationship between lower urinary tract symptoms and autonomic imbalance. We investigated the relationship between detrusor overactivity (DO) or urgency, and transient increase in blood pressure as
Externí odkaz:
https://doaj.org/article/696bb82514cb4d4aaedf65ebbefa3bc9
Autor:
Makito Miyake, Nobumichi Tanaka, Isao Asakawa, Shunta Hori, Yosuke Morizawa, Yasushi Nakai, Satoshi Anai, Kazumasa Torimoto, Katsuya Aoki, Nagaaki Marugami, Masatoshi Hasegawa, Tomomi Fujii, Noboru Konishi, Kiyohide Fujimoto
Publikováno v:
Journal of Contemporary Brachytherapy, Vol 9, Iss 4, Pp 364-372 (2017)
Purpose: We evaluated our experience with low-dose-rate salvage brachytherapy for local recurrence after primary prostate radiotherapy, and described the changes in lower urinary tract symptoms and health-related quality of life. Material and methods
Externí odkaz:
https://doaj.org/article/3753426dae5044a1b06174a1508a05f2
Autor:
Shunta Hori, Makito Miyake, Yoshihiro Tatsumi, Sayuri Onishi, Yosuke Morizawa, Yasushi Nakai, Nobumichi Tanaka, Kiyohide Fujimoto
Publikováno v:
PLoS ONE, Vol 12, Iss 4, p e0175494 (2017)
Intravesical bacillus Calmette-Guerin (BCG) treatment is the most common therapy to prevent progression and recurrence of non-muscle invasive bladder cancer (NMIBC). Although the immunoreaction elicited by BCG treatment is well documented, those indu
Externí odkaz:
https://doaj.org/article/f990a79ccda2445a90818eaf619ff53a
Autor:
Makito Miyake, Shunta Hori, Sayuri Ohnishi, Takuya Owari, Kota Iida, Kenta Ohnishi, Yosuke Morizawa, Daisuke Gotoh, Yoshitaka Itami, Yasushi Nakai, Takeshi Inoue, Satoshi Anai, Kazumasa Torimoto, Katsuya Aoki, Tomomi Fujii, Nobumichi Tanaka, Kiyohide Fujimoto
Publikováno v:
Diseases, Vol 7, Iss 2, p 44 (2019)
Background: The aim of this study is to evaluate the clinical impact of intravesical Bacillus Calmette-Guérin (BCG)-induced changes in blood/urinary immune markers. Methods: Time-course changes in blood/urinary clinical parameters and mRNA expressio
Externí odkaz:
https://doaj.org/article/92834b34eed34c998f904550eb619f38
Autor:
Satoshi Anai, Makito Miyake, Tomomi Fujii, Kiyohide Fujimoto, Nobumichi Tanaka, Kenta Onishi, Takuto Shimizu, Shunta Hori, Mikiko Onishi, Kazuki Ichikawa, Yasushi Nakai
Publikováno v:
International Journal of Urology. 28:1164-1170
OBJECTIVE To evaluate trends in risk classification at diagnosis and choice of primary therapy in patients diagnosed with prostate cancer. METHODS This retrospective study included 10 839 patients who were newly diagnosed with prostate cancer between
Autor:
Yasuhiro Hashimoto, Sadafumi Kawamura, Masaki Shiota, Takayuki Sugiyama, Takahiro Inoue, Hideki Enokida, Takahiro Osawa, Toru Shimazui, Hiroaki Yasumoto, Toshihiro Saito, Takayuki Goto, Takahiro Kojima, Hiroyuki Nishiyama, Shinichi Sakamoto, Naoki Kohei, Shogo Teraoka, Naoki Terada, Ken-ichi Tabata, Takahiro Kimura, Atsushi Takahashi, Masatoshi Eto, Hiroshi Kitamura, Kohei Hashimoto, Nobumichi Tanaka, Takuma Kato, Mikio Sugimoto, Takashi Mizowaki, Toshihiko Sakurai, Masashi Kato, Koji Mitsuzuka, Kentaro Kuroiwa, Toshiyuki Kamoto, Shintaro Narita, Yoshiyuki Nagumo, Manabu Kamiyama, Ryotaro Tomida, Hiroaki Matsumoto, Akira Yokomizo
Publikováno v:
Cancer Science
The metastatic burden is a critical factor for decision‐making in the treatment of metastatic hormone‐sensitive prostate cancer (HSPC). This study aimed to develop and validate a novel risk model for survival in patients with de novo low‐ and h
Autor:
Kohei Hashimoto, Takahiro Kojima, Takuma Kato, Naoki Terada, Shogo Teraoka, Hiroaki Matsumoto, Takashi Mizowaki, Toshihiro Saito, Hiroaki Yasumoto, Masaki Shiota, Takayuki Sugiyama, Akira Yokomizo, Kentaro Kuroiwa, Toshiyuki Kamoto, Takahiro Inoue, Toshihiko Sakurai, Koji Mitsuzuka, Hiroshi Kitamura, Manabu Kamiyama, Shinichi Sakamoto, Shintaro Narita, Naoki Kohei, Atsushi Takahashi, Nobumichi Tanaka, Yoshiyuki Nagumo, Masashi Kato, Mikio Sugimoto, Hideki Enokida, Takahiro Osawa, Ryotaro Tomida, Toru Shimazui, Takayuki Goto, Ken-ichi Tabata, Yasuhiro Hashimoto, Hiroyuki Nishiyama, Takahiro Kimura, Sadafumi Kawamura, Masatoshi Eto
Publikováno v:
Cancer Science
Metastatic burden is a critical factor for therapy decision‐making in metastatic hormone‐sensitive prostate cancer. The present study aimed to identify prognostic factors in men with high‐ or low‐metastatic burden treated with primary androge